Hosted on MSN4mon
Mirum Shares Surge More Than 90% in 6 Months: Here's Why
In August 2023, Mirum acquired all assets of Travere Therapeutics’ bile acid products, which added two other products to its commercial portfolio — Cholbam (cholic acid) capsules and Chenodal ...
Mirum Pharmaceuticals: Set Fair For Share Price Momentum - Reversing My Sell Call
Mirum Pharmaceuticals stock surged 25% and how LIVMARLI drives growth. Explore future prospects with Volixibat. Click here to ...
Hosted on MSN1mon
Why Travere Therapeutics Inc. (TVTX) Went Up On Tuesday?
A laboratory technician working on a solution of rare diseases, housed in a cholic acid capsule ... Filspari could become the first and only medicine to treat FSGS. Overall, TVTX ranks 2nd ...